Companies / Marinus Pharmaceuticals Inc
Marinus Pharmaceuticals Inc
MRNSCIK 1267813
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 9, 2021 | Smith Edward F Executive | Sell Open-market sale | Common Stock | $718.3K | -40K -75.23% | 13,288 | medium |
| Mar 27, 2024 | Braunstein Scott CEO | Exercise Option exercise | Common Stock | $214.0K | +50K +22.37% | 273,512 | low |
| Mar 9, 2021 | Smith Edward F Executive | Exercise Option exercise | Common Stock | $149.5K | +36K +202.78% | 53,644 | low |
| Feb 16, 2024 | Braunstein Scott CEO | Sell Open-market sale | Common Stock | $117.8K | -12K -5.03% | 223,512 | medium |
| Feb 11, 2025 | Braunstein Scott CEO | Other Sold to issuer | Common Stock | $98.7K | -180K -100.00% | 0 | low |
| Feb 7, 2025 | Braunstein Scott CEO | Other Sold to issuer | Common Stock | $68.8K | -125K -41.06% | 179,536 | low |
| Mar 15, 2021 | Vitullo Nicole Director | Sell Open-market sale | Common Stock | $67.4K | -4K -100.00% | 0 | low |
| Aug 7, 2023 | Braunstein Scott CEO | Sell Open-market sale | Common Stock | $61.2K | -6K -3.84% | 160,792 | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| MRNS | common | 56854Q200 |